ArticleCureus2025
Unmasking a Rare Venous-Predominant Arteriovenous Malformation: A Case of Recurrent Subarachnoid Hemorrhage Successfully Treated With Stereotactic Radiosurgery.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Long-term outcomes and radiation-induced complications following stereotactic radiosurgery for a left temporal arteriovenous malformation: illustrative case.Journal of neurosurgery. Case lessons · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Arteriovenous malformations (AVMs) are a leading cause of intracranial hemorrhage in young adults, yet venous-predominant AVMs remain exceedingly rare and diagnostically challenging, often mimicking benign developmental venous anomalies (DVAs). We present the case of an 18-year-old male who suffered from recurrent subarachnoid hemorrhages due to a venous-predominant AVM initially misidentified as a DVA. Given the lesion's deep location and high surgical risk, stereotactic radiosurgery (SRS) was selected as the primary treatment modality. Over a 64-month follow-up, the patient demonstrated progressive obliteration of the AVM, culminating in complete resolution on conventional angiography at 55 months post-SRS. This case underscores the critical role of advanced imaging in distinguishing rare AVM subtypes, the importance of multidisciplinary decision-making, and the long-term efficacy of SRS in managing high-risk vascular lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.